CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
-$0.01-6.25%
OTC PK
| 03/31/2026 | 12/31/2025 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -187.12% | -7.25% | -19,729.41% | -8,280.00% | -- |
| Total Depreciation and Amortization | 6.25% | -75.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 111.89% | 31,422.22% | 11,557.69% | -- |
| Change in Net Operating Assets | 205.41% | 23.17% | 3,325.00% | -1,325.00% | -- |
| Cash from Operations | 39.56% | 93.30% | -13,133.33% | -23,300.00% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -660.95% | 483.67% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.50% | -57.38% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -86.50% | -100.04% | 483.67% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | 1,250.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.15% | -15,300.00% | -271.11% | -- | -- |